Order Entry
United States
ContactUsLinkComponent
 
Alethia® Pertussis DNA amplification assay, Meridian Bioscience
  76437-460
 :  Meridian
 :  
undefined
Alethia® Pertussis DNA amplification assay, Meridian Bioscience
  76437-460
 :  Meridian
 :  480750
 :  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

 

  • Description:
    Alethia® Pertussis
  • Environmentally Preferable:
  • Cat. No.:
    76437-460
  • Details:
    Molecular assay for the detection of Bordetella pertussis

 

 

The Alethia™ Pertussis DNA amplification assay is a qualitative in vitro diagnostic test for the direct detection of Bordetella pertussis in human nasopharyngeal swab samples taken from patients suspected of having respiratory tract infection attributable to Bordetella pertussis.

  • With molecular results in less than one hour, long turnaround times and send out costs can be eliminated
  • Targeted detection can help physicians treat patients appropriately

The molecular accuracy of Alethia™ Pertussis provides a clear and objective evaluation of positive/negative test results. This can help to reduce the risk of spreading illness to others and allow for appropriate treatment as soon as possible.